Skip to main content

The MedTech Dive Outlook on 2023

Medical device leaders expect financial pressures to ease as companies navigate regulatory changes in Europe, planned spinoffs and product launches.

included in this trendline
  • Diabetes outlook: What Dexcom, Medtronic and other leaders are watching in 2023
  • Faster approvals among priorities as AI moves to fore
  • M&A in 2023: Spinoffs, China exits, AI opportunities poised to spur deal rebound
Note: Trendlines are a premium product, available to subscribers of our free newsletters. Access this Trendline by signing up for the MedTech Dive newsletter or enter your information if you're already subscribed.
Produced by our team of award-winning journalists, the MedTech Dive Outlook for 2023 can help you and your organization navigate the road ahead in the medical device industry.
Davide Savenije Editor-in-Chief at Industry Dive.